Epigenomics' 2009 Revenues Jump 65 Percent

The German molecular diagnostics firm launched its first IVD product for colorectal cancer during 2009, and revenues rose on milestone payments from partners.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.